Suchergebnisse - "Rongyi, Chen"

PubPharm (22)

1

Hemophagocytic lymphohistiocytosis syndrome secondary to systemic hydroa vacciniforme lymphoproliferative disorder: a case report and literature review

in: Pifu-xingbing zhenliaoxue zazhi | 2024

von Sai YANG | Mohammad Hassan HEIDARI | Ruzeng XUE | +4

2

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab : a prospective observational study

enthalten in: Arthritis research & therapy | 2023

von Rongyi, C. | Xiaojuan, D. | Jinghua, W. | +6

3

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study

enthalten in: Arthritis Research & Therapy | 2023

von Rongyi, C. | Xiaojuan, D. | Jinghua, W. | +6

4

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study

enthalten in: Arthritis Research & Therapy | 2023

von Rongyi, C. | Xiaojuan, D. | Jinghua, W. | +6

5

Circ_0084043-miR-134-5p axis regulates PCDH9 to suppress melanoma

in: Frontiers in Oncology | 2022

von Guiyue Cai | Guiyue Cai | Ruitao Zou | +10

6

Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis

enthalten in: Modern rheumatology | 2021

von Rongyi, C. | Zongfei, J. | Jiang, L. | +10

7

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension

enthalten in: Arthritis research & therapy | 2021

von Ying, S. | Sifan, W. | Yujiao, W. | +5

8

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension

enthalten in: Arthritis Research & Therapy | 2021

von Ying, S. | Sifan, W. | Yujiao, W. | +5

9

Prognostic factors in IgG4-related disease : a long-term monocentric Chinese cohort study

enthalten in: Clinical rheumatology | 2021

von Zongfei, J. | Lingying, M. | Lijuan, Z. | +8

10

Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis

in: Arthritis Research & Therapy | 2021

von Rongyi Chen | Lingying Ma | Peng Lv | +10